☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Co- Develop
BeyondSpring Signs an Exclusive Agreement with Jiangsu Hengrui to Co- Develop & Commercialize Plinabulin in Greater China
August 27, 2021
BridgeBio Collaborates with Helsinn to Co- Develop and Commercialize Infigratinib in Oncology
April 1, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.